021-51111890
购物车（）
sales@molnova.cn
ISX-1
CAS No. 909207-35-8
ISX-1 ( —— )
产品货号. M33990 CAS No. 909207-35-8
ISX-1 是一种异恶唑。 ISX-1 具有抗脂肪生成和促成骨活性。 ISX-1 可用于骨量减少和骨质疏松症的研究。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥1227 | 有现货 |
|
| 5MG | ￥1760 | 有现货 |
|
| 10MG | ￥2487 | 有现货 |
|
| 25MG | ￥3722 | 有现货 |
|
| 50MG | ￥5302 | 有现货 |
|
| 100MG | ￥7160 | 有现货 |
|
| 200MG | ￥9639 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称ISX-1
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述ISX-1 是一种异恶唑。 ISX-1 具有抗脂肪生成和促成骨活性。 ISX-1 可用于骨量减少和骨质疏松症的研究。
-
产品描述ISX-1 is an isoxazole. ISX-1 has anti-adipogenic and pro-osteogenic activities. ISX-1 can be used for the research of osteopenia and osteoporosis.
-
体外实验RT-PCRCell Line:Human bone marrow mesenchymal stem cells (hBMSCs)Concentration:0, 1.3, 6.5 and 33 μM Incubation Time:3 days Result:Inhibited the mRNA induction of PPARγ and FABP4 genes under the adipogenic differentiation of hBMSCs and showed no effect on C/EBPα expression.Western Blot Analysis Cell Line:HEK 293 cells Concentration:6.5 and 33 μM Incubation Time:6.5 and 33 μM Result:Increased both the amount of activated and total β-catenin.
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number909207-35-8
-
分子量302.35
-
分子式C14H14N4O2S
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : 50 mg/mL (165.37 mM; 超声助溶 )
-
SMILESC(NCCCN1C=CN=C1)(=O)C=2C=C(ON2)C3=CC=CS3
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Nawa, Katsuhiko et al. Discovering small molecules that inhibit adipogenesis and promote osteoblastogenesis: unique screening and Oncostatin M-like activity. Differentiation. 2013 Jul-Sep;86(1-2):65-74. ?
产品手册
关联产品
-
Methyl 4-prenyloxyci...
Methyl 4-prenyloxycinnamate is a Phenylpropanoids product that can be isolated from the barks of Cinnamomum cassia.
-
Insulin Receptor (11...
Insulin Receptor (1142 - 1153), Amide
-
P7C3
P7C3 类神经保护性氨基丙基咔唑已被证明可以阻止神经变性模型中的神经元细胞死亡。
